Aurinia Pharmaceuticals (AUPH) EBT Growth (1y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 12.59% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -148.28% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -313.33% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 71.54% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | -79.57% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -8.15% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 9,460.35% |
| 10 | Aurinia Pharmaceuticals | 2.03 Bn | 1.65 Bn | 71.20 Mn | 80.40% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 80.40% |
| Dec 31, 2025 | 2,942.63% |
| Sep 30, 2025 | 115.86% |
| Jun 30, 2025 | 1,399.05% |
| Mar 31, 2025 | 343.25% |
| Dec 31, 2024 | 104.44% |
| Sep 30, 2024 | 212.61% |
| Jun 30, 2024 | 112.18% |
| Mar 31, 2024 | 61.16% |
| Dec 31, 2023 | -4.86% |
| Sep 30, 2023 | -63.65% |
| Jun 30, 2023 | 65.83% |
| Mar 31, 2023 | 31.50% |
| Dec 31, 2022 | 22.72% |
| Sep 30, 2022 | 84.01% |
| Jun 30, 2022 | 24.44% |
| Mar 31, 2022 | 25.31% |
| Dec 31, 2021 | -311.72% |
| Sep 30, 2021 | -19.22% |
| Jun 30, 2021 | -77.05% |
| Mar 31, 2021 | -92.48% |
| Dec 31, 2020 | 89.63% |
| Sep 30, 2020 | -121.68% |
| Jun 30, 2020 | -67.09% |
| Mar 31, 2020 | -110.79% |
| Dec 31, 2019 | -426.03% |
| Sep 30, 2019 | -3.65% |
| Jun 30, 2019 | -1.13% |
| Mar 31, 2019 | 19.79% |
| Dec 31, 2018 | -335.77% |